Breaking News, Promotions & Moves

Novo Nordisk Appoints New President & CEO

Mazier Mike Doustdar succeeds Lars Fruergaard Jørgensen.

Author Image

By: Charlie Sternberg

Associate Editor

Maziar Mike Doustdar. Image courtesy of Novo Nordisk.

Novo Nordisk has appointed Maziar Mike Doustdar as President and CEO, effective August 7, 2025. Doustdar succeeds Lars Fruergaard Jørgensen, who will step down on the same date. Doustdar, currently Novo Nordisk’s executive vice president of International Operations, has a track record of creating value and driving growth. Under his leadership over the past decade, Novo Nordisk’s International Operations have more than doubled sales. Novo Nordisk Chair, Helge Lund, said: “Mike is an excepti...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters